Eledon Pharmaceuticals (ELDN) Free Cash Flow (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Free Cash Flow of -$22.6 million for Q1 2026, down 40.8% year-on-year from -$38.2 million in Q1 2025, and down 60.47% on a QoQ basis from -$14.1 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Free Cash Flow data on file, last reported at -$22.6 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 40.8% year-over-year to -$22.6 million; the trailing twelve-month figure through Mar 2026 stood at -$68.9 million (down 26.2% YoY), and the FY2025 full-year result was -$62.3 million, down 31.88% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$22.6 million, down from -$14.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$4.6 million in Q3 2022 and bottomed at -$22.6 million in Q1 2026.
- The 5-year median for Free Cash Flow is -$9.9 million (2023), against an average of -$11.8 million.
- The widest annual swing landed in 2022, when Free Cash Flow jumped 35.56%; it then slumped 168.02% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$9.5 million in 2022, then gained by 3.68% to -$9.1 million in 2023, then tumbled by 107.94% to -$19.0 million in 2024, then increased by 25.79% to -$14.1 million in 2025, then slumped by 60.47% to -$22.6 million in 2026.
- The last three Free Cash Flow figures came in at -$22.6 million (Q1 2026), -$14.1 million (Q4 2025), and -$14.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -22.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.61 Mn |
| Mar 31, 2026 | -22.61 Mn |
| Dec 31, 2025 | -14.09 Mn |
| Dec 31, 2025 | -14.09 Mn |
| Sep 30, 2025 | -14.48 Mn |
| Sep 30, 2025 | -14.48 Mn |
| Jun 30, 2025 | -17.71 Mn |
| Jun 30, 2025 | -17.71 Mn |
| Mar 31, 2025 | -16.06 Mn |
| Mar 31, 2025 | -16.06 Mn |
| Dec 31, 2024 | -18.99 Mn |
| Dec 31, 2024 | -18.99 Mn |
| Sep 30, 2024 | -11.77 Mn |
| Sep 30, 2024 | -11.77 Mn |
| Jun 30, 2024 | -7.77 Mn |
| Jun 30, 2024 | -7.77 Mn |
| Mar 31, 2024 | -8.74 Mn |
| Mar 31, 2024 | -8.74 Mn |
| Dec 31, 2023 | -9.13 Mn |
| Dec 31, 2023 | -9.13 Mn |
| Sep 30, 2023 | -12.25 Mn |
| Sep 30, 2023 | -12.25 Mn |
| Jun 30, 2023 | -8.22 Mn |
| Jun 30, 2023 | -8.22 Mn |
| Mar 31, 2023 | -9.92 Mn |
| Mar 31, 2023 | -9.92 Mn |
| Dec 31, 2022 | -9.48 Mn |
| Dec 31, 2022 | -9.48 Mn |
| Sep 30, 2022 | -4.57 Mn |
| Sep 30, 2022 | -4.57 Mn |
| Jun 30, 2022 | -6.22 Mn |
| Jun 30, 2022 | -6.22 Mn |
| Mar 31, 2022 | -8.16 Mn |
| Mar 31, 2022 | -8.16 Mn |
| Dec 31, 2021 | -9.21 Mn |
| Dec 31, 2021 | -9.21 Mn |
| Sep 30, 2021 | -7.09 Mn |
| Sep 30, 2021 | -7.09 Mn |
| Jun 30, 2021 | -7.45 Mn |
| Jun 30, 2021 | -7.45 Mn |
| Mar 31, 2021 | -5.17 Mn |
| Mar 31, 2021 | -5.17 Mn |
| Dec 31, 2020 | -9.43 Mn |
| Dec 31, 2020 | -9.43 Mn |
| Sep 30, 2020 | -561,000.00 |
| Sep 30, 2020 | -561,000.00 |
| Jun 30, 2020 | -3.02 Mn |
| Jun 30, 2020 | -3.02 Mn |
| Mar 31, 2020 | -2.20 Mn |
| Mar 31, 2020 | -2.20 Mn |
| Dec 31, 2019 | -2.02 Mn |
| Dec 31, 2019 | -2.02 Mn |
| Sep 30, 2019 | -2.89 Mn |
| Sep 30, 2019 | -2.89 Mn |
| Jun 30, 2019 | -4.92 Mn |
| Jun 30, 2019 | -4.92 Mn |
| Mar 31, 2019 | -4.02 Mn |
| Mar 31, 2019 | -4.02 Mn |
| Dec 31, 2018 | -3.35 Mn |
| Dec 31, 2018 | -3.35 Mn |
| Sep 30, 2018 | -2.94 Mn |
| Sep 30, 2018 | -2.94 Mn |
| Jun 30, 2018 | -3.33 Mn |
| Jun 30, 2018 | -3.33 Mn |
| Mar 31, 2018 | -2.27 Mn |
| Mar 31, 2018 | -2.27 Mn |
| Dec 31, 2017 | -2.61 Mn |
| Dec 31, 2017 | -2.61 Mn |
| Sep 30, 2017 | -3.42 Mn |
| Sep 30, 2017 | -3.42 Mn |
| Jun 30, 2017 | -8.03 Mn |
| Jun 30, 2017 | -8.03 Mn |
| Mar 31, 2017 | -882,000.00 |
| Mar 31, 2017 | -882,000.00 |
| Dec 31, 2016 | -1.28 Mn |
| Dec 31, 2016 | -1.28 Mn |
| Sep 30, 2016 | -1.48 Mn |
| Sep 30, 2016 | -1.48 Mn |
| Jun 30, 2016 | 7.59 Mn |
| Jun 30, 2016 | 7.59 Mn |
| Mar 31, 2016 | -9.76 Mn |
| Mar 31, 2016 | -9.76 Mn |
| Dec 31, 2015 | -9.09 Mn |
| Dec 31, 2015 | -9.09 Mn |
| Sep 30, 2015 | -10.41 Mn |
| Sep 30, 2015 | -10.41 Mn |
| Jun 30, 2015 | -11.15 Mn |
| Jun 30, 2015 | -11.15 Mn |
| Mar 31, 2015 | -11.15 Mn |
| Mar 31, 2015 | -11.15 Mn |
| Dec 31, 2014 | -6.46 Mn |
| Dec 31, 2014 | -6.46 Mn |
| Sep 30, 2014 | -4.47 Mn |
| Sep 30, 2014 | -4.47 Mn |
| Jun 30, 2014 | -5.43 Mn |
| Jun 30, 2014 | -5.43 Mn |
| Mar 31, 2014 | -4.79 Mn |
| Mar 31, 2014 | -4.79 Mn |
| Dec 31, 2013 | -6.83 Mn |
| Dec 31, 2013 | -6.83 Mn |